Gene transfer of the costimulatory molecules of B7-1 and of immunostimulatory cytokine transcripts and by ELISA B7-2 induces a potent antitumor immune response in a quantification of cytokines in the supernatant. Stimulation variety of tumor models. B cell neoplasms including mulof T cells with rAAV/B7-1 or rAAV/B7-2 transduced LP-1 tiple myeloma (MM) often show little or no expression of cells resulted in an up to 10-fold increase of T cell prolifer-B7 antigens; they are therefore a potential target for this ation when compared with LP-1 cells transduced with approach. To increase the expression of human B7 genes rAAV/Neo. Similar results were obtained with RPMI 8226 in MM cells, both genes and the neomycin phosphocells. Both rAAV/B7-1 and rAAV/B7-2 transduced LP-1 transferase gene were packaged into recombinant adenocells stimulated the T cell secretion of IL-2 and IFN-␥. Furassociated virus vectors (rAAV). The resulting recombinant thermore, [ 51 Cr] release assays showed that rAAV/B7-1 or viruses rAAV/B7-1, rAAV/B7-2 and rAAV/Neo were used rAAV/B7-2 transduced LP-1 cells induced a cytolytic T cell to transduce the MM cell lines LP-1 and RPMI 8226. This (CTL) response, in contrast to LP-1 cells transduced with allowed the transduction of up to 80% of LP-1 cells 4 days rAAV/Neo. In all assays, the effects of rAAV/B7-1 and after infection with purified rAAV particles. The response rAAV/B7-2 were similar. Taken together, the results show of human allogeneic T cells to rAAV/B7-1 and rAAV/B7-2 that rAAV-mediated transfer of B7 genes into MM cell lines transduced, ␥-irradiated LP-1 cells was assessed by is able to enhance the antitumor T cell response and to [ 3 H]thymidine incorporation, by RT-PCR-based detection elicit a cytolytic T cell response.
Introduction challenge with wild-type, B7-negative tumors. [8] [9] [10] [11] [12] [13] [14] There Cytolytic T cells (CTLs) play a major role in the rejection are several variables influencing the efficiency of tumor of immunogenic tumors. 1 Therefore, many different strarejection, eg the immunogenicity of the tumor and the tegies have been used to enhance the specific antitumor amount of B7 molecule expressed by the tumor cell. 9, 15 CTL response in order to eradicate residual tumor cells. While there is overwhelming evidence that transfer of For full activation of T cells at least two signals are B7-1 and B7-2 genes into tumor cells induces a CTL required, ie an antigen-specific signal delivered through response at least against immunogenic tumors, 16 less is the T cell receptor (TCR) and a costimulatory signal known about the effects of B7 gene combinations used through the CD28 molecule on the T cell surface. CD28 for this purpose. Moreover, the combined gene transfer is stimulated by counter-receptors designated B7-1 of both B7-1 and B7-2 has not been studied for B cell (CD80) and B7-2 (CD86) on antigen presenting cells lymphoma vaccination so far. In the multiple myeloma (APC). [2] [3] [4] [5] Only an efficient costimulation enables the (MM) cell line J558L, tumor protection was demonstrated expansion of CD8 + cytolytic T lymphocytes (CTL). 6, 7 It after combined retroviral gene transfer of B7-1 and cytocould be demonstrated that B7 expression on tumor cells kine genes (IL-4 or IL-7); the effects of B7-2 were not increased the antitumor immune response. In several studied. 17, 18 In another study no antitumor effect after rodent tumor models, B7 transduced tumors were vaccination with B7-1 transduced A20 lymphoma cells was observed. 19 Therefore, it was the purpose of this study to determine whether gene transfer of B7-1 and/or B7-2 enhanced the CTL response against B7-negative most experiments. B7 genes were transduced into LP-1 cells with an optimized recombinant adeno-associated virus (rAAV) vector. 20, 21 To date, there is only one report using AAV vectors for gene transfer into lymphoma cells. Zhang and colleagues 22 used the AAV vector technology to transfer the synthetic type I interferon gene (IFN-con1) into an immunoblastic lymphoma cell line, resulting in tumor growth suppression and tumor regression. Our study shows that rAAV-mediated gene transfer of both B7-1 and B7-2 is able to induce a cytolytic T cell response against neoplastic B cells.
Results
Rescue of intact high-yield rAAV virions using a new packaging system Using a new packaging system, 20 we sought to demonstrate that intact packaging of rAAV virions occurred with the different plasmids used (see Materials and methods). Therefore, COS-7 cells were transfected with pAAVRnLacZ, pAAV/Neo or pAAV/B7-2 and the helper plasmid pSVoriAAV. After 48 h, cells were infected with Ad5 at a multiplicity of infection (MOI) of 10. Figure 1a demonstrates that all the rescued vectors, rAAV/lacZ, rAAV/Neo and rAAV/B7-2, showed a characteristic pattern of bands representing duplex monomers (dm) and duplex dimers (dd), as well as larger multimeric forms. Electron microscopy analysis confirmed that rAAV particles had a similar morphology to wild-type AAV, as published previously. 20 The production capacity of the new packaging system was tested by co-electroporation of 2 × 10 8 COS-7 cells with 400 g pAAV/B7-2 and 400 g pSVoriAAV. After packaging rAAV particles (see Materials and methods) cell lysates were fractionated on isopycnic CsCl gradients and the density of each faction (refractive index) and the distribution of rAAV genomes across the gradient was determined by a dot blot technique in comparison to serial dilutions of a plasmid standard (Figure 1b) . The peak for AAV genomes was detected in fractions with a refractive index of 1.3725-1.3710 (corresponding to a density of 1.42-1.40 g/ml) and contained a concentration of 2 × 10 11 viral particles/ml. Transfer of B7-1 or B7-2 genes into B7-negative efficiency was assessed by FACS analysis. Usually, more than 50% of cells expressed the transgene after 2 days, and nearly 80% of cells after 4 days, as shown prewith G418 (400 g/ml) for another 2 weeks to ensure stable expression of the transgene(s). rAAV/Neo infected viously. 20 Furthermore, there was no alteration of B7 expression after infection with rAAV/Neo as compared cells showed no up-regulation of B7 antigens during these selective culture conditions. Expression of B7-1 with uninfected controls. After rAAV/B7-1 or rAAV/B7-2 infection, B7-positive cells were enriched by and/or B7-2 on the surface of transduced LP-1 cells was checked by flow cytometry; only clones expressing simimagnetic cell sorting (MACS) using ferrochrom-labeled B7-1 and B7-2 MAbs. This allowed a population of LPlar amounts of B7-1 and/or B7-2 (у95%-positive cells and similar mean fluorescence intensities) 20 were used for 1 cells to be obtained which expressed B7-1 or B7-2 at Ͼ90%. Transduced cells were cultured under selection subsequent assays. After ␥-irradiation (100 Gy), LP-1 cells were co-incubated with allogeneic monocyte-depleted, both LP-1/B7-1 and LP-1/B7-2 cells, a maximal T cell response was achieved with 1250-5000 cells resulting in peripheral blood lymphocytes (PBLs; Ͼ90% CD3 + T cells) of a healthy donor for 72 h, and T cell proliferation was an up to 10-fold increase of counts in comparison to controls ( Figure 3 ). As little as 300 transduced LP-1 cells were assessed. Figure 2 shows that LP-1 cells transduced with rAAV/B7-1 (LP-1/B7-1) or rAAV/B7-2 (LP-1/B7-2) sufficient to induce a significant T cell response. In contrast, only very high amounts of LP-1/Neo cells were induced a much higher [ 3 H]thymidine incorporation of T cells (mean ± s.e.m. 11307 ± 790 c.p.m. and 11918 ± 2285 able to induce a T cell response. c.p.m., respectively) than cells infected with rAAV/Neo (LP-1/Neo: 1125 ± 634 c.p.m.). There was no significant
The mixture of B7-1-and B7-2-positive cells or the simultaneous co-expression of B7-1 and B7-2 on LP-1 difference of the T cell response to LP-1/B7-1 or LP-1/B7-2 cells. In order to demonstrate that the effect was cells do not further enhance the T cell response Since it was not clear whether the combined transfer of due to the transduction of the costimulatory molecules, cells were co-incubated with MAbs against B7-1 or B7-B7-1 and B7-2 genes into B7-negative tumor cells stimulates T cells in an additive manner, we performed a series 2; this reduced the These experiments revealed that mixtures of LP-1/B7-1 phoma cell line, Karpas 299, or the MM cell line, RPMI-8226, was also able to increase the T cell proliferation and LP-1/B7-2 cells did not induce a higher T cell response than single transductants. We then examined indicating that rAAV-mediated gene transfer of B7-1 or B7-2 could induce a T cell reponse which was otherwise whether the simultaneous expression of B7-1 and B7-2 on LP-1 cells caused additional effects. Again, LP-1/B7-hardly detectable (data not shown).
Since it has been reported that B7-1 and B7-2 are 1 or LP-1/B7-2 cells were more effective in stimulating T cells than untransduced or LP-1/Neo cells. The effects expressed at different times after activation of APCs, [23] [24] [25] we were interested to study the effects of B7-1 and B7-of the combined transduction of B7-1 and B7-2 into LP-1 cells (LP-1/B7-1*2) was slightly, but reproducibly 2, when T cells were exposed to transduced tumor cells at varying times. If 1.25 × 10 3 LP-1/B7-2 cells were superior to single transductants or the mixture of cells (LP-1/B7-1 + B7-2). Since we saw a small increase of the presented to 5 × 10 4 PBLs and 1.25 × 10 3 LP-1/B7-1 cells were added 24 h later, T cell proliferation was somewhat T cell response to LP-1/B7-1*2 cells in some experiments, the experiments were repeated 10 times with different T higher (means ± s.e.m. 14170 ± 1333) than with sequential stimulation of LP-1/B7-1-positive cells followed by LPcell donors to exclude donor-specific effects. Table 1 summarizes these data and illustrates that T cell proliferation 1/B7-2 cells (means ± s.e.m. 9364 ± 488 c.p.m.; n = 6 wells for each mixture of cells). Therefore, the early presence was enhanced by LP-1/B7-1 or LP-1/B7-2 cells by +48.4% to +60.4% in comparison to untransduced conof B7-2 on LP-1 cells might be more potent than B7-1 during priming of a T cell response.
trols, respectively (P Ͻ 0.01; Table 1 ). Mixing LP-1/B7-1 and LP-1/B7-2 cells only slightly increased the response to +76.1%; this effect was significantly different to LPSmall numbers of B7-1 or B7-2 transduced LP-1 cells stimulate T cells 1/Neo and LP-1/B7-1 cells (P Ͻ 0.01 and P = 0.04, respectively) but not from LP-1/B7-2 cells (P = 0.05). In To evaluate further the efficiency of the B7-induced T cell response, we examined next how many B7-positive LP-1 contrast, the stimulation with LP-1/B7-1*2 cells induced a further increase in T cell proliferation to +125.6% which cells were needed to induce an allogeneic T cell response. A fixed number of PBLs (5 × 10 4 ) was incubated with was different both to LP-1/Neo cells, to single transductants, and to the mixture of LP-1/B7-1 and LP-1/B7-2 150-20 000 LP-1/B7-1, LP-1/B7-2 or LP-1/Neo cells. For To confirm further the stimulatory effects of B7 gene transfer on cytokine production by T cells, cytokine expression was investigated on the RNA level. Semiquantitative RT-PCR was carried out using specific primers for IL-2, IL-4 and IFN-␥. For comparison of the RNA quality and amount, ␤-actin was amplified as control. The experiments showed an enhanced activity for all three cytokines after T cell activation by LP-1/B7-1, LP-1/B7-2, LP-1/B7-1+2 or LP-1/B7-1*2. PCR products were amplified from nonstimulated T cells after 35 cycles. However, after B7 stimulation cytokine transcription was largely enhanced: transcripts for IL-2 and IFN-␥ could be detected after 20 cycles and IL-4 after 25 cycles (data not shown). Variations in cytokine stimulation by B7-1, B7-2, as well as by the mixture or combination of both molecules could not be detected.
Figure 2 Proliferation of human T cells in response to human MM cells (LP-1) transduced with rAAV/B7-1 or rAAV/B7-2. Human T cells were prestimulated with concanavalin A, and irradiated LP-1 cells which were transduced with a control virus (LP-1/Neo) or with specific transgene (LP-1/B7-1 or LP-1/B7-2) were added. T cell proliferation was assessed after 72 h by [

H]-thymidine incorporation assay. The transductants were incubated with anti-human B7-1 or B7-2 mAb and T cell proliferation was detected. Data represent means (n = 6 wells for each mixture of cells) + s.e.m. (bars). Background was defined as T cell proliferation after stimulation with concanavalin
LP-1 cells transduced with rAAV/B7-1 and rAAV/B7-2, but not with rAAV/Neo induce a cytolytic T cell response in vitro In order to determine the influence of rAAV/B7-1 or rAAV/B7-2 transduction on the cytolytic response of allogeneic T cells to LP-1 cells, freshly isolated peripheral blood mononuclear cells were primed by co-cultivation with ␥-irradiated (100 Gy) B7-positive or B7-negative LP-1 cells for 6 days. Thereafter, lysis of [ 51 Cr]-labeled LP-1 cells was used to assess the CTL response. Figure 6 shows that LP-1/B7-1 or LP-1/B7-2 targets were lysed more efficiently by effector T cells primed with LP-1/B7-1 or LP-1/B7-2, respectively, than LP-1/Neo cells by effector tor T cells primed with LP-1/B7-1*2 at an equal efficiency as the B7 transfectants. cells were performed. Cytolytic effector T cells were generated against LP-1/B7-1*2 as described above and their cytolytic activity was tested against two different [ 51 Cr]-lysis from 35.9% to 24.9%, while competition of LP-1/B7-labeled targets: the priming LP-1 transfectant (LP-1/B7-1*2 showed no effect (Figure 7b ). 1*2) and the NK-sensitive K562 cell line. In each case, When these effector T cells were assayed in the presunlabeled LP-1/B7-1*2 and K562 cells were used as comence and absence of saturating concentrations of various petitors in order to block specific lysis. As shown in Figmonoclonal antibodies, it was found that lysis of LPure 7, the effector population contains at least two separ-1/B7-1*2 could be reduced by 34% with anti-CD3 and by ate components, one reactive against the B7 transfectant 59% with anti-CD8, whereas lysis of K562 was unaffected (LP-1/B7-1*2), the other reactive against K562. Thus, killby either of these two antibodies (data not shown). ing of labeled LP-1/B7-1*2 (27.2% without competitors, Figure 7a ) was reduced far more effectively by unlabeled cells of the same line (down to 15.3%) than by K562 comDiscussion petitors (down to 22%). Similarly, cold K562 were much more efficient competitors of K562 target cell lysis than
The present study shows that a MHC class I-and II-positive, B7-negative MM cell line, LP-1, is deficient in stimul-LP-1/B7-1*2 cells, because they reduced the uncompeted 51 
Figure 6 Cytolytic activity of human allogeneic T cells against B7 transduced LP-1 cells. Lysis of rAAV transduced LP-1 cells was evaluated in a 4 h [ 51 Cr]-release assay at different E:T ratios. K562 were used as NK-sensitive control targets for non-MHC restricted effector cells. The percentage of specific lysis was calculated according to the formula given in Materials and methods.
Figure 7 Cold target inhibition of specific lysis of B7 transduced LP-1 (a) and K562 (b) cells by unlabeled competitor cells. Cytolytic effector T cells were generated against LP-1/B7-1*2. Two different targets were used to assess their lytic activity: (a) LP-1/B7-1*2 and (b) K562 cells. Both targets were labeled with
Cr as described in Materials and methods. Different numbers of unlabeled K562 and LP-1/B7-1*2 cells were used as competitors (cold target inhibition) to block lysis by effector cells. The E:T ratio was 10:1.
ating an allogeneic T cell reponse, and that rAAVtoward NK cell lysis. 26 Dohring and colleagues 27 could show cytolytic responses of B7 transduced tumor cells mediated gene transfer of B7-1 and B7-2 into LP-1 cells may correct this defect in antigen presentation. LP-1 cells even in the absence of T-helper and accessory cells. A human NK leukemia cell line expressing CD28 was able transduced with B7-1 or B7-2 genes stimulated the proliferation of allogeneic T cells and the secretion of T cell to lyse human cell lines expressing B7 without MHC restriction. 28 Taken together, our results are in agreement cytokines (IL-2, IFN␥). Transduced cells showed an increased susceptibility to cytolysis by allogeneic T cells.
with the literature in showing that enhancing expression of B7-1 or B7-2 genes on tumor cells stimulates both T This effect was due in part to a T cell response since it could partially be blocked by monospecific anti-CD3 and cells and NK cells. While several studies addressed the role of B7 gene anti-CD8 antibodies, as well as by cold target inhibition. Parts of the cytolytic effects were caused by NK cells, transfer into various solid tumor cells, this is one of the few studies applying this immunomodulating strategy since a fraction of the effector cell population reacted against MHC-negative K562 cells. This phenomenon is for human MM. Cayeux and colleagues 17, 18 studied the effects of B7-1 gene transfer in a MM cell line, especially known from other studies: expression of B7-1 renders a NK-resistant mouse T lymphoma cell line sensitive in combination with transduction of cytokine genes (IL-
4, IL-7).
Recently, it was shown that the expression of arguing for the crucial role of this molecule for the negative regulation of T cell responses. [40] [41] [42] The immune adhesion and B7 costimulatory molecules on freshly isolated human lymphoma cells can be up-regulated by response seems to be a mutually competitive process involving CD28 and CTLA-4 on the activated T cell and CD40 ligation or EBV transformation which allowed induction of a potent stimulation of alloreactive T cells. [29] [30] [31] B7-1 and B7-2 on the APCs. A strength-of-signal hypothesis was introduced: low antigen density involves CD28 The effects of a direct B7 gene transfer into lymphoid cells have rarely been studied so far, probably because ligation and B7-2-mediated costimulation resulting in a primary T cell response. While the immune response prothe transduction efficiency into lymphoid tumor cells by known gene transfer vectors is relatively low. In our gresses, B7-1 and B7-2 are both activated and promote the expansion of a more Th2 directed phenotype. Finally, study, which used an improved rAAV vector, a relatively efficient transduction of B7 genes into some lymphoid if costimulation exceeds a certain level, immune responses might be down-regulated by an up-regulation cell lines (LP-1, RPMI 8226) was achieved. When transduced as single genes by rAAV vectors, B7-1 and B7-2 of CTLA-4 on the activated T cells. 39 This argues for the critical role of the amount of costimulatory molecules were equally potent in inducing a T cell response. Similarly, Lanier et al 32 showed in murine P815 mastocytoma expressed on APCs. Our data show that even small amounts of B7 molecules presented by MM cells are able cells that both B7-1 and B7-2 are potent costimulators of T cells. In some contrast, Gajewski 33 showed that B7-1, to trigger an allogeneic T cell response and result in an enhanced CTL activity against tumor cells in vitro. Other but not B7-2 induced an efficient primary T cell response against P815 mastocytoma cells. Similarly, B7-1 was studies indicate that high amounts of B7 antigens might be necessary to induce an antitumor immune response shown to be superior to B7-2 in its capacity to protect against wild-type tumor challenge in a murine model of in vivo. 15 This indicates that the amount of B7-1 or B7-2 to be transduced might be a critical parameter in tumor acute myeloid leukemia. 34 In our study, B7-1 and B7-2 had some additive effects, in particular when covaccination. It can be anticipated that further improvements are expressed on LP-1 cells, a phenomenon not described so far. The effects of B7-1 and B7-2 were also characterized needed to produce potent vaccines for lymphoma. First, additional (costimulatory) molecules might be needed to by an enhanced secretion of IL-2 in the supernatant of T cells. Again, the IL-2 secretion was not different in induce a potent antitumor response. 43 This is supported by the observation that certain B7-positive lymphoma response to B7-1 and B7-2, in accordance with previous studies. 23, 32, 35 However, our observations are in some cells which express costimulatory molecules like B7-1 or B7-2 can still escape a CTL response. Alternative stracontrast to a recent report which indicated that the combined expression of B7-1 and B7-2 on tumor cell was less tegies have been proposed for the creation of vaccines for lymphoma patients, including the possibility of creating effective in stimulating an antitumor response than the expression of B7-1 alone. 36 It can be speculated that a lymphoma vaccines by using idiotypes or idiotypepulsed dendritic cells; 44 this approach has already been certain competition between B7-1 and B7-2 for binding to CD28 can cause this phenomenon, alternatively a hypshown to be effective in a clinical pilot study. 45 Lymphoma vaccines using costimulation by B7-1 and/or B7-erstimulation can decrease the T cell response by interaction with the negative regulatory CTLA-4 molecule or by 2 may be improved by a subsequent, short CTLA-4 blockade at the time of vaccination and allow selective amplipromoting Th2 responses that inhibit tumor immunity.
There is recent evidence to suggest that B7-1 and B7-fication of immune responses without induction of hyperimmunity or autoimmunity against lymphoid 2 may have distinct roles. 37 For example, Kuchroo and colleagues 38 showed in an experimental allergic encetissue. 46, 47 Combined gene transfer of B7 molecules and the gene of the TNF cytokine family ligand 4-1BB might phalomyelitis model that B7-1 and B7-2 activate the Th1 and Th2 pathways differentially: B7-1 preferentially acts open another avenue for potent cancer vaccines. Expression of 4-1BB on a B cell lymphoma cell line stimuas a costimulator for the generation of Th1 cells with activation of IL-2 and IFN-␥ secretion thus triggering a celllated the IL-2 production and proliferation of T cells, and this effect could not be inhibited by ␣-B7-1 or ␣-B7-2 mediated immunity, while B7-2 is a more potent inducer of a Th2 response with production of IL-4 and IL-10, thus antibodies. 43 Among these different strategies, transfer of B7 genes into lymphoid tumor cells may have been negresulting in a humoral immune response. In another study, B7-1 and B7-2 costimulation was equivalent at lected in the past; our results provide evidence that this approach might be promising for creating lymphoma inducing IL-2 and IFN␥ production, while B7-1 more effectively costimulated GM-CSF production and B7-2 vaccines, at least for B7-negative human MM or lymphoma. increased the generation of IL-4 and TNF␤. 23 Bluestone 39 postulated that B7-2 has a dominant role during primary T cell responses, whereas B7-1 is activated in later stages
Materials and methods
of immune responses and thus functions in prolonging primary T cell responses. It will be important to determine how these potentially different modes of action Cell culture Human lymphoid cell lines LP-1, Karpas-299 and RPMI interfere with the effects of tumor vaccines produced by B7-1 or B7-2 gene transfer.
8226 were obtained from the German collection of Microorganisms and Cell Cultures, Braunschweig, Germany. In addition to the effects of B7/CD28 ligation, T cell costimulation is influenced by CTLA-4 which has a
The LP-l cell line was originally established from the peripheral blood of a 56-year-old female with MM (IgG 1 higher affinity with both B7-1 and B7-2 than CD28 and seems to down-regulate or terminate the T cell response.
EBV-negative) in leukemic transformation. 48 Karpas-299 cells were cultured from the peripheral blood of a 25-It was shown that CTLA-4-deficient mice develop an uncontrolled and lethal lymphoproliferative disorder, year-old man with T cell non Hodgkin's lymphoma. 49 RPMI 8226, a human IgG 1 chain secreting myeloma was transduction efficacy and establishing selective conditions by adding G418 (400 g/ml) to the medium. obtained from the American Type Culture Collection (ATCC, CCL-155), Rockville, MD, USA. LP-1 cells were Doubly transduced LP-1 cells expressing both B7-1 and B7-2 were maintained as described previously: 20 LP-1 cultured in Iscove's medium (GIBCO, Gaithersburg, MD, USA) supplemented with 10% FCS, Karpas-299 and cells were first transduced with B7-1 coding AAV particles (rAAV/B7-1), sorted for B7-1 antigen expression RPMI 8226 cells were maintained in RPMI-1640 supplemented with 20% FCS, 100 g/ml penicillin, 100 by MACS, and maintained in selective long-term culture (400 g/ml G418). Cells expressing more than 95% B7-1 g/ml streptomycin, and 2 mm l-glutamine. Cells were cultured at 37°C in a humidified atmosphere with 5%
antigen were then transduced with rAAV/B7-2, enriched for B7-2 by MACS and cultured in G418 for another 2 CO 2 . The NK-sensitive cell line K562 was a generous gift of Dr Christian Strasburger (Medizinische Klinik, weeks. Finally, a cell population strongly positive (у95%) for both B7-1 and B7-2 was received. Mü nchen, Germany) and maintained in RPMI-1640 supplemented with 10% FCS. Antibodies for blocking experiHirt's extraction ments were kindly provided by Professor Rieber (Institut For both replication and excision-rescue assays, lowfü r Immunologie, Universitä t Mü nchen, Germany 195; Dianova-Immunotech). Fluorescence was measured was performed as described. 20 Based on a packaging syswith a Coulter Epics XL-MCL (Coulter Electronics, tem using the SV40 origin of replication driven helper Miami, FL, USA). plasmid pSVoriAAV and the large T antigen positive packaging cell line COS7, titers of Ͼ10 10 genomic Generation of effector T cells particles/ml were achieved routinely. 20 Titers were Lymphocytes were isolated from fresh blood of healthy assessed by assaying CsCl fractions for the presence of donors by Ficoll-Hypaque density gradient centrifugpackaged rAAV genomes by DNA dot blot hybridization, depleted from monocytes by adherence to plastic ation. 52 Particle titers were determined by comparing the tissue culture flasks and used for proliferation assays signal intensity of the gradient fractions with that of a immediately thereafter. For priming of cytolytic T lymstandard plasmid. The signal was quantified using a phocytes, 5 × 10 6 PBLs were cocultured for 6 days with Phosphor Imager (Storm 860; Molecular Dynamics Inc).
5 × 10 5 ␥-irradiated (100 Gy) stimulating LP-1 cells in tissue culture flasks containing RPMI-1640 supplemented rAAV transduction with l-glutamine (2 mm), penicillin (100 g/ml), streptoHuman lymphoid cell lines were washed in serum-free mycin (100 g/ml), and 15% human AB serum (Promega, medium, and 1 × 10 5 to 1 × 10 6 cells were resuspended in Heidelberg, Germany). serum-free medium with viral lysate (10-50 l) yielding a total volume of 100 l. After incubation for 1-2 h at T cell proliferation assay T lymphocytes (5 × 10 4 ) were seeded in 200 l Iscove's 37°C, cells were transferred to six-well dishes and cultured in full medium for another 48 h before assessing medium supplemented with 10% FCS in a 96-well flat-bottom microtiter plate and cultured at 37°C for 3 days.
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